RITSUKO KOMAKI to Injections, Subcutaneous
This is a "connection" page, showing publications RITSUKO KOMAKI has written about Injections, Subcutaneous.
Connection Strength
0.013
-
Phase I study of weekly alternating therapy with irinotecan/cisplatin and etoposide/cisplatin for patients with small-cell lung cancer. Clin Lung Cancer. 2003 Jul; 5(1):40-5.
Score: 0.013